| Abstract | Uvod: Bolesnici koji boluju od kronične bubrežne insuficijencije i liječe se dijalizom imaju visok rizik za razvoj kardiovaskularnih incidenata, a hipertenzija pojedinačno je najznačajniji faktor rizika. Cilj: Cilj istraživanja je utvrditi stupanj regulacije krvnog tlaka, te usporediti vrijednosti arterijskog krvnog tlaka kod bolesnika na hemodijalizi s bolesnicima na peritonejskoj dijalizi. Metode i ispitanici: Istraživanje je provedeno retrospektivno tijekom 2017.godine u Općoj bolnici Zadar. Korištene su metode prikupljanja, analize i sinteze podataka. Podaci su prikupljeni iz bolničkog informacijskog sustava. U istraživanje je uključeno 47 bolesnika (30 bolesnika s hemodijalize i 17 bolesnika s peritonejske dijalize). Ispitanici su izabrani slučajnim odabirom, neovisno o dobi, spolu, komorbiditetima i ordiniranoj terapiji. Rezultati: Na hemodijalizi 76,67% bolesnika boluje od hipertenzije, a na peritonejskoj 94,11 %. Rezultati ukazuju da razlika za sistolički krvni tlak kod bolesnika na hemodijalizi u odnosu na bolesnike na peritonejskoj nije statistički značajna (t=0.64, df=233, p=1.97, p>0.05) te vrijednosti za dijastolički krvni tlak također nisu statistički značajne (t= 1.26, df=233, p=1.97, p>0.05). Nadalje, razlika nije statistički značajna kod bolesnika na hemodijalizi s obzirom na dob bolesnika (t=1.09, df=148, p=1.98, p>0.05. Osim toga, dobiveni podaci ukazuju na to da bolesnici na hemodijalizi kojima je ordinirano 3 ili više antihipertenziva imaju lošije reguliran krvni tlak od onih koji imaju manje ordiniranih antihipertenziva (t=7.45, df=148, p=1.98 odnosno p<0.05). Kontrolu krvnog tlaka ima 46,67% bolesnika na hemodijalizi, a na peritonejskoj 47,06%. Zaključak: Unatoč napretku medicine i dostupnosti raznih lijekova i metoda kontrole krvnog tlaka, hipertenzija predstavlja izazov za sve zdravstvene djelatnike te bolesnike koji boluju od kronične bubrežne insuficijencije s obzirom na moguće posljedice. |
| Abstract (english) | Introduction: Patients who are suffering from chronic kidney failure and are on dialysis treatment have a high risk of developing cardiovascular incidences, and hypertension is the most important risk factor. Objective: The research goal is to determine the degree of regulation and compare the value of arterial blood pressure in patients on hemodialysis with patients on peritoneal dialysis. Methods and respondents: The research is conducted retrospectively during 2017 at the General Hospital of Zadar. Methods of collecting, analyzing and synthesizing data have been used. Data were collected from the hospital information system. The study included 47 patients (30 patients on hemodialysis and 17 patients on peritoneal dialysis). Subjects were randomly selected, regardless of age, sex, comorbidity, and ordinated therapy. Results: On hemodialysis, 76.67% of patients has hypertension and 94.11% of patients on peritoneal dialysis. In the study, the difference in systolic blood pressure in patients on hemodialysis compared to patients on peritoneal is not statistically significant (t = 0.64, df = 233, p = 1.97, p> 0.05) and the values for diastolic blood pressure are also not statistically significant (t = 1.26, df = 233, p = 1.97, p> 0.05). Furthermore, the difference is not statistically significant in patients on hemodialysis due to age (t = 1.09, df = 148, p = 1.98, p> 0.05) In addition, the data obtained suggest that hemodialysis patients with 3 or more antihypertensive drugs have poorer regulated blood pressure than those with less ordinated antihypertensives (t = 7.45, df = 148, p = 1.98 and p <0.05). Blood pressure control has 46.67% of patients on hemodialysis and 47.06% on peritoneal dialysis. Conclusion: Despite the advancement of medicine and the availability of various medicines and methods of blood pressure control, it is a challenge for all healthcare professionals and patients suffering from chronic renal insufficiency if we take in consideration possible consequences. |
